Dr Reddy informed the bourses on Monday that it has launched Fulvestrant injection, 250 mg/5 ml (50 mg/ml) per single-dose syringe, a therapeutic equivalent generic version of Faslodex (fulvestrant) injection, 250 mg/5 ml (50 mg/ml), approved by United States Food & Drug Administration (USFDA)